摘要
目的探讨Ⅰ期乳腺癌保乳术后乳腺三维适形加速外照射(APBI-3DCRT)治疗的近期疗效。方法选择2003年2月至2006年3月在湖北省肿瘤医院行Ⅰ期乳腺癌保乳术后患者89例,自愿接受APBI-3DCRT治疗的患者57例为APBI-3DCRT组,全乳腺照射(WBI)治疗的患者32例为WBI组。使用8 MV光子线进行APBI-3DCRT和WBI计划设计,设定4~5个照射野,处方剂量为每次3.4 Gy,每天2次,间隔6 h,总剂量34 Gy。观察两组患者的生存率、复发率、急性放射性损伤发生率和乳房美容效果。结果 APBI-3DCRT组急性放射性皮肤反应发生率和肺损伤发生率(10.53%和5.26%)较WBI组(28.13%和18.75%)低(P<0.05)。APBI-3DCRT组乳房美容优良率(92.98%)较WBI组(75.00%)高(P<0.05)。结论Ⅰ期乳腺癌保乳术后APBI-3DCRT治疗近期疗效好。
Objective To evaluate the clinical feasibility of APBI-3DCRT in stageⅠbreast cancer after breast conserving surgery.Methods 57 patients were treated with APBI-3DCRT voluntarily as APBI-3DCRT group,and 32 patients treated with whole breast irradiation as WBI group,and all of cases were from Feb 2003 to Mar 2006 in Hubei Tumor Hospital APBI-3DCRT and WBI were designed by means of the photon beans with energy of 8 MN,and four to five irradiation fields were set,the prescri-ption dose was about 3,4 Gy with 2 times per day at intervals of 6 hours,the total dose was 34 Gy.Survival rate,recurrence rate,acute irradiation skin responses,irradiation lung injury and breast appearance after the two therapies were appraised.Results The 5-year local recurrence rate,5-year metastasis rate and 5-year survival rate of APBI-3DCRT group was 5.26%、3.51% and 100%,respectively,which was of no significant difference with WBI group(P0.05).The acute irradiation skin responses rate of APBI-3DCRT and WBI group was 10.53% and 28.13%,the irradiation lung injury rate of the two groups were 5.26 %and 18.75%.The breast appearance excellent rate of APBI-3DCRT and WBI group was 92.98% and 75.00%(P0.05).Conclusion APBI-3DCRT is feasible for stageⅠbreast cancer patients after conserving surgery.
出处
《重庆医学》
CAS
CSCD
北大核心
2011年第27期2724-2725,2728,共3页
Chongqing medicine
关键词
乳腺肿瘤
放射疗法
乳腺三维适形加速外照射
breast neoplasms
radiotherapy
after breast-conserving surgery
Accelerated
partial breast irradiation
3-dimensional conformal radio-therapy